-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie Affirms FY2026 Adj EPS Guidance of $13.87-$14.07 vs $14.08 Est

Benzinga·09/03/2026 13:17:48
語音播報
AbbVie (NYSE:ABBV) affirms FY2026 Adj EPS guidance from $13.87-$14.07 to $13.87-$14.07 vs $14.08 analyst estimate..